Eli Lilly & Co. (LLY) Share Price ($):56.48 Price Change: -0.45 (-0.79%)

Expand Company Information
Volume 2,895,850 Avg Volume 6,002,179
Day's Low $56.22 Day's High $56.61
52-wk Low $39.16 52-wk High $57.28
Previous Close $56.93 Open Price $56.45
Dividend $ 0.49 Yield 3.47%
Market Cap 63,804,300,000 P/E (Forward) 14.48
Chart for LLY
Exchange: NYSE Industry: Pharmaceuticals & Biotechnology Last Trade: 4:01 PM ET 4/5/2013
Last 10 Quotes: What's This?
    Find a Broker »
    Article Time Date Source
    Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures 8:50 AM Apr 4, 2013  PR
    The Morning Ledger: Pharma Firms Embrace Pay Clawbacks 6:53 AM Apr 4, 2013  WSJ.com
    Drug Firms Expand Powers to Recoup Pay 7:44 PM Apr 3, 2013  WSJ.com
    Lilly Confirms Date and Conference Call for First-Quarter 2013 Financial Results Announcement 4:23 PM Apr 3, 2013  PR
    Lilly Aims to Spend Added $180 Million to Increase Scope of Indianapolis Insulin Plant Expansion 8:58 AM Apr 2, 2013 Dow Jones Global News Select
    Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations 7:59 AM Apr 2, 2013  PR
    Today's Analysis on Bristol-Myers Squibb, Eli Lilly & Co., Endo Pharma, and Allergan 8:02 AM Mar 28, 2013  PR
    European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Company's empagliflozin*, an investigational type 2 diabetes treatment 11:23 AM Mar 26, 2013  PR
    CEO Pay Declines at Lilly, Rises at Bristol-Myers 3:04 PM Mar 25, 2013 Dow Jones Global News Select
    Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment 7:59 AM Mar 25, 2013  PR
    American College of Endocrinology (ACE) to emphasize emergency planning for people with diabetes at National Hurricane Conference 8:00 AM Mar 25, 2013  PR
    Eli Lilly Lists Shares on NYSE's Paris Market, Withdraws from LSE 5:32 AM Mar 25, 2013 Dow Jones Global News Select
    Boehringer Ingelheim and Lilly initiate MARLINA -2- 8:00 AM Mar 19, 2013  PR
    Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta(R) (linagliptin) tablets in patients with type 2 diabetes and albuminuria 8:00 AM Mar 19, 2013  PR
    New Study of Cialis(R) (tadalafil) Tablets -2- 11:16 AM Mar 18, 2013  PR
    New Study of Cialis(R) (tadalafil) Tablets Co-administered with Finasteride Meets Primary Endpoint in Men with Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia 11:16 AM Mar 18, 2013  PR
    Improving Lives: Breakthroughs & Collaborations - Research Report on Pfizer, Merck, Bristol-Myers Squibb, J&J and Lilly 8:01 AM Mar 18, 2013  PR
    Zoetis: Too Many Folks' Pet Stock 3:38 AM Mar 16, 2013  Barrons.com
    FDA Opens Safety Review of Diabetes Drugs 12:38 PM Mar 14, 2013  WSJ.com
    FDA Conducting Safety Review Of Certain Diabetes Drugs 12:00 PM Mar 14, 2013 Dow Jones Global News Select
    • Print Snapshot
    • Stock Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports
    tools

    Stock Screener

    Portfolio Tracker

    See More Tools